Medications

Bempedoic acid improves outcomes in statin-intolerant patients

The cholesterol-lowering drug bempedoic acid reduced the combined rate of major adverse cardiovascular events by 13%, meeting its primary endpoint in a large study of patients with high cholesterol who were unable to tolerate ...

Medical research

New aptamer drug for bone anabolic therapies

A research team led by Hong Kong Baptist University (HKBU) has identified a molecular target for bone anabolic therapies using a selected aptamer that serves as an inhibitor of sclerostin, a protein that prevents bone growth. ...

Cardiology

Adult ADHD linked to elevated risk of cardiovascular diseases

Adults with ADHD are at greater risk of developing a range of cardiovascular diseases than those without the condition, according to a large observational study led by researchers at Karolinska Institutet and Örebro University. ...

page 4 from 28